One 2021 study tracked 12 patients with chronic knee pain who got BPC-157 shots and found that seven of them reported feeling relief for more than six monthsmoderately encouraging, but hardly the kind of research that alone leads to a blockbuster drug being approved
Autophagy inhibition in those tumors affects multiple aspects of cancer metabolism such as lipid metabolism (233), amino acid recycling (234) and nucleotide homeostasis (235), making it a promising therapeutic strategy for RAS-driven cancers
BPC-157 acts systemically in the digestive tract to combat leaky gut, IBS, gastro-intestinal cramps, and Crohns disease
Free shipping on every domestic order
There are some serious risks associated with the GLP-1 receptor agonists
As of 2026, the FDA has not approved any therapeutic peptides for musculoskeletal or orthopedic applications